The Health Minster of Panama, Luis Sucre, said on 7 February 2021 that Panama is seeking to acquire over eight million COVID-19 vaccine doses to inoculate about 80% of the country's residents, Reuters news agency reported on Monday.
According to Sucre, Panama has requested about one million doses from the COVID-19 vaccine portfolio under the COVAX facility coordinated by the World Health Organisation to support lower-income countries.
It will acquire a further three million doses from US pharmaceutical firm Pfizer Inc and the same amount from Russia, which has developed the Sputnik V COVID-19 vaccine.
Sucre added that Panama also aims to acquire 1.1 million doses manufactured by AstraZeneca PLC and 300,000 shots produced by Johnson & Johnson.
Reportedly, Panama has a population of about 4.2 million people but most COVID-19 vaccines require two shots spaced several weeks apart.
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access